isosorbide-5-mononitrate has been researched along with Hepatic Encephalopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraldes, JG; Bosch, J; Garcia-Pagan, JC; Rodés, J; Tarantino, I; Turnes, J | 1 |
| Aracil, C; Balanzó, J; González, B; Guarner, C; Kolle, L; López-Balaguer, JM; Miñana, J; Soriano, G; Villanueva, C | 1 |
| Bañares, R; Bosch, J; Bru, C; Echenagusia, A; Escorsell, A; García-Pagán, JC; Gilabert, R; Granados, A; Moitinho, E; Piqueras, B | 1 |
2 trial(s) available for isosorbide-5-mononitrate and Hepatic Encephalopathy
| Article | Year |
|---|---|
Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Ascites; Esophageal and Gastric Varices; Female; Hemodynamics; Hepatic Encephalopathy; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nadolol; Prognosis | 2004 |
TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.
Topics: Adrenergic beta-Antagonists; Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Health Care Costs; Hemorrhage; Hepatic Encephalopathy; Humans; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Prospective Studies; Quality of Life; Retreatment; Secondary Prevention; Varicose Veins | 2002 |
1 other study(ies) available for isosorbide-5-mononitrate and Hepatic Encephalopathy
| Article | Year |
|---|---|
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Topics: Antihypertensive Agents; Ascites; Bacterial Infections; Cohort Studies; Drug Therapy, Combination; Female; Hemodynamics; Hemorrhage; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Probability; Prognosis; Propranolol; Recurrence; Risk Factors; Survival Analysis; Time Factors; Varicose Veins; Vasodilator Agents | 2003 |